Document is current
Any future updates will be listed below
-
Authors
Birkner, Benjamin
Rech, Jürgen
Edelmann, Edmund
Verheyen, Frank
Schett, Georg
Stargardt, Tom
-
Funding
Funding for this research was provided by:
Friedrich-Alexander-Universität Erlangen-Nürnberg
- License Information
-
More Information
Article History
Accepted: 15 March 2023
First Online: 23 June 2023
Declarations
:
: B. Birkner, J. Rech, E. Edelmann, F. Verheyen, G. Schett, and T. Stargardt report grants from the Federal Joint Committee (<i>Innovationsfonds</i>) during the conduct of the study. E. Edelmann reports personal fees from Abbvie, Roche Pharma, Pro Generica, MSD, GlaxoSmithKline, and Gilead Sciences. The contribution of FV to the study was in his capacity of an employee of a statutory health insurance fund (Techniker Krankenkasse).
: All studies mentioned here,were performed in compliance with the principles of the declaration of Helsinki and Good Clinical Practice (GCP).
